Option Care Health

Option Care Health is a leading American healthcare services company specializing in home and alternate-site infusion therapy. Formed in 2019 through the merger of Option Care Enterprises and BioScrip, the company operates a nationwide network of pharmacies and infusion suites that deliver complex biologic and specialty medications directly to patients' homes, physician offices, and other non-hospital settings. Its services cover a broad range of chronic and acute conditions, including immune deficiencies, neurological disorders, infectious diseases, and nutritional support. As the largest independent infusion provider in the U.S., Option Care Health partners with health plans, hospital systems, and pharmaceutical manufacturers to improve patient outcomes while reducing the cost of care. The company went public via the merger and trades on the NASDAQ under the ticker OPCH. It is headquartered in Bannockburn, Illinois, and serves patients across all 50 states.

Option Care Health was created in 2019 when Option Care Enterprises, a leading home infusion provider, merged with BioScrip, a specialty pharmacy and infusion services company. The merger combined Option Care's extensive clinical expertise and national footprint with BioScrip's specialty pharmacy capabilities, creating the largest independent home and alternate-site infusion provider in the United States. The combined company began trading on the NASDAQ under the ticker OPCH. Since the merger, Option Care Health has focused on expanding its network of ambulatory infusion suites, enhancing its digital patient management platforms, and securing contracts with major health plans and health systems. The company has also pursued strategic acquisitions to broaden its therapeutic areas and geographic reach. In recent years, Option Care Health has benefited from the broader shift of healthcare delivery from hospitals to home and community settings, a trend accelerated by the COVID-19 pandemic. The company continues to invest in clinical programs, nursing workforce, and technology to support complex therapies such as immunoglobulin, oncology, and biologics. As of the mid-2020s, Option Care Health remains a publicly traded company and a key player in the U.S. infusion services market.

• 2019

  Option Care Enterprises and BioScrip merge to form Option Care Health, creating the largest independent home infusion provider in the U.S.

• 2019

  Option Care Health begins trading on NASDAQ under ticker OPCH.

Largest independent home infusion provider in the U.S., focused on high-touch, cost-effective care outside hospitals.

• Home infusion therapy

  Administration of intravenous medications and biologics in a patient's home.

• Specialty pharmacy

  Dispensing and management of complex, high-cost medications for chronic conditions.

• Ambulatory infusion suites

  Outpatient centers where patients receive infusion therapies in a clinical setting.

1. 1Option Care Health official websiteoptioncarehealth.com
2. 2McKesson, private equity firm buy home infusion company, Option Care Health - Managed Healthcare Executivenews.google.com
3. 3Stocks making the biggest moves premarket: Constellation Energy, Option Care Health, Lennar, P&G and morecnbc.com